Phase 1 Study of MST-168 in Participants With Advanced Solid Malignant Tumors
Clinical trial NCT07644650 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07644650
- Sponsor
- Mabsoft Therapeutics (Shanghai) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-06-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.